Diabetes Treatment
-
{
- All
- News
- Videos
-
Complaint Filed Against Telugu Health Influencer Over 'Type-1 Diabetes Cure' Claims: Why Stopping Insulin Can Be Fatal
Type-1 diabetes occurs when the pancreas produces little or no insulin. Insulin allows glucose in the blood to enter cells which is then used for energy. People with Type-1 diabetes need insulin every day as part of their treatment.
-
Ozempic, Wegovy And Zepbound May Cause Vision Loss? Indian Doctors Say Patients Need Not Panic
Reports link GLP-1 drugs like Ozempic and Wegovy to rare sudden vision loss called NAION, but doctors urge patients not to stop treatment without advice.
-
Novo Responds To GLP-1 Drug Ozempic Causing Vision Loss Claims: What Semaglutide Data Shows
Novo Nordisk says a large pooled analysis of clinical trials found no increased risk of rare NAION with semaglutide. Here is what the new evidence means for diabetes patients in India amid concerns over sudden vision loss.
-
Metabolic Surgery May Offer Remission In Some Patients With Uncontrolled Diabetes: AIIMS Doctor
Dr Manjunath Maruti, professor in the Department of Surgery said the procedure should not be viewed as a treatment for every person with diabetes, but as one of the evidence-based options for patients whose blood sugar remains uncontrolled despite medicines and lifestyle changes.
-
Type 1 Diabetes: Can Insulin Ever Be Replaced By A Pill? Doctors Answer
Dr Anoop Misra and Dr Ambrish Mithal explain why insulin injections can't be replaced by a pill. Here is what happened to a diabetes patient who tried to do so, and why you should only follow what a doctor has prescribed for diabetes management.
-
Exclusive: Novo Nordisk Launches World's First Once-Weekly Insulin In India
Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly basal insulin-cutting the annual injection count for diabetes patients from 365 to just 52.
-
Diabetes Can Harm Your Eyes Before Symptoms Appear: Doctor Explains How To Prevent It
Diabetic retinopathy, caused by high blood sugar, is a leading cause of vision loss globally, affecting millions including 65 million in India.
-
Breakthrough: Peptide Pills Likely To Make Daily Insulin Injections Unnecessary Soon
Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation helps insulin survive digestion and enter the bloodstream, offering hope for easier diabetes management.
-
Breakthrough: Peptide Pills Likely To Make Daily Insulin Injections Unnecessary Soon
Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation helps insulin survive digestion and enter the bloodstream, offering hope for easier diabetes management.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Scientists Reportedly Reversed Type 1 Diabetes by Reprogramming Patient's Fat Cells into Insulin-Producing Cells
Chinese researchers have, for the first time, reprogrammed a woman’s fat cells to become insulin-producing pancreatic cells, reversing her need for insulin injections for over a year. In this study, fat cells were chemically reverted into stem-like cells and transformed into islet cells, which are normally found in the pancreas. The cells, implan...
-
Beat Prediabetes Initiative for India launched by International Diabetes Federation South East Asia
To bring forth the need for greater awareness on the management of diabetes, Dr Shashank Joshi, Chair of IDF South East Asia, said, "Acting Early at Prediabetes or "early Diabetes" is important to win the war against type 2 diabetes.
-
Complaint Filed Against Telugu Health Influencer Over 'Type-1 Diabetes Cure' Claims: Why Stopping Insulin Can Be Fatal
Type-1 diabetes occurs when the pancreas produces little or no insulin. Insulin allows glucose in the blood to enter cells which is then used for energy. People with Type-1 diabetes need insulin every day as part of their treatment.
-
Ozempic, Wegovy And Zepbound May Cause Vision Loss? Indian Doctors Say Patients Need Not Panic
Reports link GLP-1 drugs like Ozempic and Wegovy to rare sudden vision loss called NAION, but doctors urge patients not to stop treatment without advice.
-
Novo Responds To GLP-1 Drug Ozempic Causing Vision Loss Claims: What Semaglutide Data Shows
Novo Nordisk says a large pooled analysis of clinical trials found no increased risk of rare NAION with semaglutide. Here is what the new evidence means for diabetes patients in India amid concerns over sudden vision loss.
-
Metabolic Surgery May Offer Remission In Some Patients With Uncontrolled Diabetes: AIIMS Doctor
Dr Manjunath Maruti, professor in the Department of Surgery said the procedure should not be viewed as a treatment for every person with diabetes, but as one of the evidence-based options for patients whose blood sugar remains uncontrolled despite medicines and lifestyle changes.
-
Type 1 Diabetes: Can Insulin Ever Be Replaced By A Pill? Doctors Answer
Dr Anoop Misra and Dr Ambrish Mithal explain why insulin injections can't be replaced by a pill. Here is what happened to a diabetes patient who tried to do so, and why you should only follow what a doctor has prescribed for diabetes management.
-
Exclusive: Novo Nordisk Launches World's First Once-Weekly Insulin In India
Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly basal insulin-cutting the annual injection count for diabetes patients from 365 to just 52.
-
Diabetes Can Harm Your Eyes Before Symptoms Appear: Doctor Explains How To Prevent It
Diabetic retinopathy, caused by high blood sugar, is a leading cause of vision loss globally, affecting millions including 65 million in India.
-
Breakthrough: Peptide Pills Likely To Make Daily Insulin Injections Unnecessary Soon
Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation helps insulin survive digestion and enter the bloodstream, offering hope for easier diabetes management.
-
Breakthrough: Peptide Pills Likely To Make Daily Insulin Injections Unnecessary Soon
Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation helps insulin survive digestion and enter the bloodstream, offering hope for easier diabetes management.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Scientists Reportedly Reversed Type 1 Diabetes by Reprogramming Patient's Fat Cells into Insulin-Producing Cells
Chinese researchers have, for the first time, reprogrammed a woman’s fat cells to become insulin-producing pancreatic cells, reversing her need for insulin injections for over a year. In this study, fat cells were chemically reverted into stem-like cells and transformed into islet cells, which are normally found in the pancreas. The cells, implan...
-
Beat Prediabetes Initiative for India launched by International Diabetes Federation South East Asia
To bring forth the need for greater awareness on the management of diabetes, Dr Shashank Joshi, Chair of IDF South East Asia, said, "Acting Early at Prediabetes or "early Diabetes" is important to win the war against type 2 diabetes.
